Despite increasing experimental evidence regarding the anti-inflammatory abilities of RelB against CS, neither expression of RelB nor its expression relative to other inflammatory mediators has been studied in the context of COPD at stable state or during exacerbation. The gene discussed is RELB; the disease is chronic obstructive pulmonary disease.